Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Exhibition > Online Symposium - Cell and Gene Therapy 2024
  1. Online Symposium - Cell and Gene Therapy 2024

    1. Mar20-21, 2024, 9AM PDT/12PM EDT/4PM GMT
    2. Online
    3. ACROBiosystems and Others
    Check more symposium details below.
    Click the button to enter our raffle.
  2. Agenda:

    ACROBiosystems is proud to speak and sponsor Technology Networks “Cell and Gene Therapy Online Symposium 2024.”



    Advances in cell and gene therapies are transforming the way we treat disease and injury. Join us for the second annual Cell and Gene Therapy online symposium, where expert speakers will discuss the current therapeutic landscape, covering ground-breaking research in cancer immunotherapy, vaccines, stem cells and vectors.


    This online symposium will explore:

    - CAR-T cell therapy in cancer - from R&D to patient

    - Lentiviral vectors in gene therapy

    - Genetic aberration in human pluripotent stem cells

    - Transcriptomic precision oncology



    Considerations in using GMP grade Raw Materials when Manufacturing Cell Therapies and Other Biologics



    Growth factors are a cornerstone in the intricate landscape of cell therapy manufacturing, playing multifaceted roles essential to produce biologics and other advanced therapeutic medicines. These biomolecules are intricately utilized throughout various manufacturing phases. As growth factors, they stimulate cell reproduction for desired therapeutic compounds as well as differentiate stem cells into cells of interest. After the initial adoption of several cell therapies, focus has become on ensuring manufacturing consistency, quality, and reliability in biopharmaceutical manufacturing. As such, quality control of cell therapies requires a multi-faceted approach for QC of not only the final therapeutic, but also raw materials that go into manufacturing cell therapies. Herein, we explore the different key methods and new assay validation procedures behind GMP product development to ensure a safe raw material for use in therapeutic manufacturing. We also highlight key facets of growth factor ‘grades’ that are associated with different stages of cell therapy manufacturing. As the biopharmaceutical industry continues to evolve and innovate, cell therapy manufacturers need to further emphasize the need for suppliers to ensure these tools are high-quality and provided at the required structure to continue to provide the foundational elements in pursuing improved global healthcare outcomes.



    An Ouyang, Ph.D., Product Manager

    As the Product Manager at ACROBiosystems, An Ouyang adopts a comprehensive approach, providing end-to-end solutions to address the unmet needs of customers in Cell and Gene Therapy, Antibody Drug, and Vaccine development, manufacturing, and clinical trials. Collaborating closely with the R&D and marketing teams at ACRO, An is dedicated to ensuring the delivery of top-notch products and services that not only meet but exceed customer expectations. This commitment contributes to the overall success of our valued clientele. An plays a pivotal role in enhancing their satisfaction, establishing ACROBiosystems as a trusted partner in the dynamic fields of drug development.

New & Hot Products

This web search service is supported by Google Inc.

Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
+1 888-377-6111
1 Innovation Way, Newark, DE 19711, USA

Leave a message